glp-1-directed nmda receptor antagonism for obesity treatment New Developments in Pharmacological of and Type 2 Diabetes—Beyond and within GLP-1 Agonists GLP-1-directed NMDA receptor antagonism for
Pay in 4 interest-free payments of $5.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18





























